Activist 13D/13G Filings - Oncternal Therapeutics Inc. (ONCT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-13
5:12 pm
Sale
13GOncternal Therapeutics, Inc.
ONCT
VANGUARD GROUP INC2,860,906
4.85%
-3,234decrease
(-0.11%)
View
2022-07-08
4:56 pm
Sale
13GOncternal Therapeutics, Inc.
ONCT
BlackRock Inc.
BLK
1,005,532
2%
-2,192,006decrease
(-68.55%)
View
2022-02-04
4:12 pm
Purchase
13GOncternal Therapeutics, Inc.
ONCT
BlackRock Inc.
BLK
3,197,538
6.5%
3,197,538increase
(New Position)
View
2021-02-16
5:04 pm
Sale
13GOncternal Therapeutics, Inc.
ONCT
ARMISTICE CAPITAL LLC1,280,930
3%
-295,541decrease
(-18.75%)
View
2021-02-16
09:48 am
Sale
13GOncternal Therapeutics, Inc.
ONCT
CVI Investments Inc.0
0%
-2,500,000decrease
(Position Closed)
View
2020-12-18
4:05 pm
Purchase
13DOncternal Therapeutics, Inc.
ONCT
HYDE JOSEPH R III1,468,142
2.99%
38,084increase
(+2.66%)
View
2020-12-18
12:06 pm
Purchase
13GOncternal Therapeutics, Inc.
ONCT
CVI Investments Inc.2,500,000
6.4%
2,500,000increase
(New Position)
View
2020-07-23
4:36 pm
Purchase
13DOncternal Therapeutics, Inc.
ONCT
Shanghai Pharmaceuticals (HK) Investment Ltd4,069,089
19.9%
4,069,089increase
(New Position)
View
2020-05-29
5:06 pm
Purchase
13GOncternal Therapeutics, Inc.
ONCT
ARMISTICE CAPITAL LLC1,576,471
9.1%
1,576,471increase
(New Position)
View
2020-02-14
4:04 pm
Unchanged
13GOncternal Therapeutics, Inc.
ONCT
PERCEPTIVE ADVISORS LLC0
0%
0
(Unchanged)
View
2019-08-01
07:30 am
Purchase
13DOncternal Therapeutics, Inc.
ONCT
HYDE JOSEPH R III1,430,058
9%
1,430,058increase
(New Position)
View
2019-06-18
2:56 pm
Purchase
13DOncternal Therapeutics, Inc.
ONCT
Shanghai Pharmaceutical (USA) Inc.2,495,114
16.2%
2,495,114increase
(New Position)
View